Skip to content
MMJ Gazette
  Monday 4 August 2025
  • About
  • Contact Us
  • Privacy Policy
  • Terms and Conditions
  • Authors
  • Home
  • News
  • CBD
  • Cannabis
  • Drugs
  • Marijuana
  • Tobacco
  • Law
Trending
August 3, 2025Cannabis Dispensaries Rethink Retail: Design That Sells, Not Just Serves August 2, 2025Legal Weed’s Tax Nightmare: How Cannabis Firms Are Pushing Back Against 280E August 2, 2025Kentucky Gears Up for First Legal Medical Marijuana Sales by Autumn July 31, 2025Hemp THC Ban Pulled from Senate Bill After McConnell–Paul Face-Off July 30, 2025Oklahoma’s Marijuana Legalisation Fight Is Back—And It’s Getting Personal July 30, 2025Starting a Cannabis Business? Here’s What You Really Need to Know First July 29, 2025New York’s Legal Weed Market Nears $1.5 Billion, But How Many Shops Can It Really Handle? July 29, 2025Texas Lawmaker Pushes Cannabis Legalisation Bill During Heated Hemp Debate July 28, 2025Cannabis Shops Are Getting a Makeover – and Sales Are Going Up July 26, 2025State Attorneys General Push Congress to Fix Outdated Marijuana Banking Laws
MMJ Gazette
MMJ Gazette
  • About
  • Contact Us
  • Privacy Policy
  • Terms and Conditions
  • Authors
MMJ Gazette
  Health  Pioneering Sleep: The Dawn of Fast-Absorption CBD Tablets
HealthNews

Pioneering Sleep: The Dawn of Fast-Absorption CBD Tablets

Lars BeckersLars Beckers—April 4, 20240
FacebookTwitterPinterestLinkedInTumblrRedditVKWhatsAppEmail

The pharmaceutical landscape is witnessing a revolutionary stride with the introduction of a new, fast-absorbing CBD tablet aimed at treating insomnia. This innovation emerges from a strategic collaboration between dsm-firmenich and OMG Pharma, marking a significant leap in patient-centric healthcare.

Orally dispersible tablets are set to transform the way CBD is administered, offering a swift and efficient method of drug delivery. These tablets dissolve under the tongue, bypassing the digestive system and ensuring rapid absorption into the bloodstream.

 CBD Tablets

The Science Behind the Breakthrough

The collaboration leverages dsm-firmenich’s expertise in high-quality GMP CBD active pharmaceutical ingredients and advanced formulation capabilities. The focus is on enhancing bioavailability, a critical factor in ensuring the medication’s effectiveness.

OMG Pharma’s dedication to innovative cannabinoid medicine research complements dsm-firmenich’s mission to deliver solutions that address unmet patient needs. Together, they aim to introduce the world’s first regulatory-approved over-the-counter CBD medication for sleep disorders.

The Clinical Pathway

A series of clinical trials are set to commence, with a focus on sleep, anxiety, and pain. These trials are a testament to OMG Pharma’s commitment to patient-centered research and development. The insomnia trial, in particular, will be a double-blind, randomized, placebo-controlled study involving 300 patients.

The goal is to assess the efficacy of a sublingual CBD tablet in treating insomnia, with doses ranging from 75mg to the maximum allowed under current regulations.

FacebookTwitterPinterestLinkedInTumblrRedditVKWhatsAppEmail

Lars Beckers

Lars Beckers is a distinguished senior content writer at MMJ Gazette, bringing a wealth of experience and expertise to the realm of medical marijuana and cannabis-related content. With a deep understanding of the industry and a passion for sharing knowledge, Lars's articles offer readers comprehensive insights and engaging narratives in the dynamic world of cannabis. Known for his meticulous research, clarity of expression, and commitment to delivering high-quality content, Lars brings a seasoned perspective to his work, educating and informing audiences on the latest trends and developments in the field.

Iowa’s Legislative Leap: Stricter Hemp Product Regulations and Expanded Medical Cannabis Access
Cannabis Raid in Oakland Yields $10M in Illicit Products, Authorities Say
Related posts
  • Related posts
  • More from author
Cannabis

Cannabis Dispensaries Rethink Retail: Design That Sells, Not Just Serves

August 3, 20250
Marijuana

Legal Weed’s Tax Nightmare: How Cannabis Firms Are Pushing Back Against 280E

August 2, 20250
Marijuana

Kentucky Gears Up for First Legal Medical Marijuana Sales by Autumn

August 2, 20250
Load more
Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

SEARCH
PROMOTIONS
RECENT POSTS
  • Cannabis Dispensaries Rethink Retail: Design That Sells, Not Just Serves
  • Legal Weed’s Tax Nightmare: How Cannabis Firms Are Pushing Back Against 280E
  • Kentucky Gears Up for First Legal Medical Marijuana Sales by Autumn
  • Hemp THC Ban Pulled from Senate Bill After McConnell–Paul Face-Off
  • Oklahoma’s Marijuana Legalisation Fight Is Back—And It’s Getting Personal
  • Starting a Cannabis Business? Here’s What You Really Need to Know First
  • New York’s Legal Weed Market Nears $1.5 Billion, But How Many Shops Can It Really Handle?
  • Texas Lawmaker Pushes Cannabis Legalisation Bill During Heated Hemp Debate
  • Cannabis Shops Are Getting a Makeover – and Sales Are Going Up
  • State Attorneys General Push Congress to Fix Outdated Marijuana Banking Laws
    © MMJ Gazette. 2024
    • About
    • Contact Us
    • Privacy Policy
    • Terms and Conditions
    • Authors